References
- Abanades S., Farré M., Barral D., Torrens M., Closas N., Langohr K., Pastor A., de la Torre R. Relative abuse liability of gamma‐hydroxybutyric acid, flunitrazepam and ethanol in club drug users. Journal of Clinical Psychopharmacology 2007; 27: 625–638
- Bennett W. R., Wilson L. G., Roy‐Byrne P. P. Gamma‐hydroxybutyric acid (GHB) withdrawal: a case report. Journal of Psychoactive Drugs 2007; 39: 293–296
- Craig K., Hernan F., McManus J. L., Bania T. C. Severe gamma‐hyroxybutyrate withdrawal: a case report and literature review. Journal of Emergency Medicine 2000; 18: 65–70
- Dyer J., Roth B., Hyma B. Gamma‐hydroxybutyrate withdrawal syndrome. Annals of Emergency Medicine 2001; 37: 147–153
- Galloway G. P., Frederick S. L., Staggers F. E., Gonzales M., Stalcup S. A., Smith D. E. Gamma‐hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997; 92: 89–96
- McDaniel C. H., Miotto K. A. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. Journal of Psychoactive Drugs 2001; 33: 143–149
- McDonough M., Kennedy N., Glasper A., Bearn J. Clinical features and management of gamma‐hydroxybutyrate (GHB) withdrawal: a review. Drug and Alcohol Dependence 2004; 75: 3–9
- Miotto K., Darakjian J., Basch J., Murray S., Zogg J., Rawson R. Gamma‐hydroxybutyric acid: patterns of use, effects and withdrawal. American Journal of Addiction 2001; 10: 232–241
- Palmer R. B. Gamma‐butyrolactone and 1, 4‐butanediol: abused analogues of gamma‐hydoxybutyrate. Toxicological Reviews 2004; 23: 21–31
- Price G. In‐patient detoxification after GHB dependence. British Journal of Psychiatry 2000; 177: 181
- Rosenberg M. H., Deerfield L. J., Baruch E. M. Two cases of severe gamma‐hydoxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management. American Journal of Drug and Alcohol Abuse 2003; 29: 487–496
- Roth R. H., Giarman N. J. Natural occurrence of gamma‐hydroxybutyrate in mammalian brain. Biochemical Pharmacology 1970; 19: 1087–1092
- Stephens B. G., Baselt R. C. Driving under the influence of GHB?. Journal of Analytical Toxicology 1994; 18: 357–358
- Tarabar A. F., Nelson L. S. The gamma‐hydroxybutyrate withdrawal syndrome. Toxicological Reviews 2004; 23: 45–49
- Wojtowicz J. M., Yarema M. C., Wax P. M. Withdrawal from gamma‐hydroxybutyrate, 1,4‐butanediol and gammabutyrolactone: a case report and systematic review. Canadian Journal of Emergency Medical Care 2008; 10: 69–74
- Wood D. M., Warren‐Gash C., Ashraf T., Greene S. L., Shather Z., Trivedy C., Clarke S., Ramsey J., Holt D. W., Dargan P. I. Medical and legal confusion surrounding gamma‐hydroxybutyrate (GHB) and its precursors gamma‐butyrolactone (GBL) and 1,4‐butanediol (1,4‐BD). QJM: Monthly Journal of the Association of Physicians 2008; 101: 23–29